C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/17/2004	EP0939798B1 Antifungal proteins, dna coding therefore, and hosts incorporating same
11/17/2004	EP0920501B8 Neuritin, a neurogene
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
11/17/2004	CN1547590A Humanized anti-LT-beta-R antibodies
11/17/2004	CN1547486A Antibodies to OPGL
11/17/2004	CN1547480A Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivati
11/17/2004	CN1546527A Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application
11/17/2004	CN1546526A Method for preparing IgY for SARS
11/17/2004	CN1546521A Transfer factor specific for SARS virus and method for preparing same
11/17/2004	CN1546515A Immune RNA specific for SARS virus and method for preparing same
11/17/2004	CN1546172A Hyper-immune serum for resisting SARS virus and its preparation
11/17/2004	CN1545922A Gamma globulin health food (SARS health food) and manufacturing process thereof
11/17/2004	CN1176106C Single-chain antibody resisting human gastric cancer and its application
11/16/2004	WO2006009525A2 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/16/2004	US6820011 Three-dimensional structure of complement receptor type 2 and uses thereof
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818754 For therapy/diagnosis/research; forensics/genetic mapping/mutation detection
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818749 Variants of humanized anti carcinoma monoclonal antibody cc49
11/16/2004	US6818748 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against Venezuelan equine encephalitis virus (VEE)
11/16/2004	US6818744 For diagnosis/prevention/treatment of neoplasia; antitumor agents
11/16/2004	US6818743 Intercellular adhesion molecule (i-cam) for modulation of ligand/receptor binding/cloning reactions; drug screening of antiinflammatory/anticancer agents; genetic engineering
11/16/2004	US6818449 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of skin and cancer disorders
11/16/2004	US6818418 Protein scaffolds for antibody mimics and other binding proteins
11/16/2004	US6818408 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
11/16/2004	US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004	US6818219 Reagent for detecting and monitoring viral infections
11/16/2004	US6818218 Prevention and treatment of amyloidogenic disease
11/16/2004	US6818216 Antibody for use in the treatment of viral infection
11/16/2004	US6818215 Antibodies to senescent cell-derived inhibiters of DNA synthesis
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	CA2525291A1 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/11/2004	WO2004097414A1 METHOD OF MEASURING INSULIN RECEPTOR α SUBUNIT
11/11/2004	WO2004097052A2 Methods for prognosis and treatment of solid tumors
11/11/2004	WO2004097041A2 Screening method for binding molecules
11/11/2004	WO2004097019A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	WO2004097018A1 Process for producing recombinant antibody
11/11/2004	WO2004097009A2 METHOD TO IDENTIFY AGENTS THAT ACTIVATE OR INHIBIT IKKi
11/11/2004	WO2004097006A1 Process for the production of biological substances by perfusion culturing of suspended animal cells
11/11/2004	WO2004096989A2 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	WO2004096976A2 Spex compositions and methods of use
11/11/2004	WO2004096835A1 Nematode pppt-like sequences
11/11/2004	WO2004096833A2 Inducers of recombinant protein expression
11/11/2004	WO2004096273A1 Methods for treating interleukin-6 related diseases
11/11/2004	WO2004096271A1 Methods for treating cancer using an immunotoxin
11/11/2004	WO2004096179A1 Zinc-containing sustained-release composition, its preparation, and method for producing the same
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004096122A2 Use of ngf antagonists and opioids for treating pain
11/11/2004	WO2004087757A3 Antibodies with enhanced ability to immunomodulate cell functions
11/11/2004	WO2004068139A3 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
11/11/2004	WO2004065422A3 Cancerous disease modifying antibodies
11/11/2004	WO2004044227A3 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	WO2004032852A3 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
11/11/2004	WO2004020404A3 Modified transferin-antibody fusion proteins
11/11/2004	WO2004010935A3 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
11/11/2004	WO2004009773A3 Methods and compositions for activating or inhibiting vegf-d and vegf-c
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003100080A3 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224894 Methods and use of motoneuronotrophic factor
11/11/2004	US20040224891 Methods for the early diagnosis of ovarian cancer
11/11/2004	US20040224386 Protein tyrosine kinases
11/11/2004	US20040224375 Sandwich assays for collagen fragments
11/11/2004	US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224323 PAK5 screening methods
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004	US20040224310 Anti-paratopic antibody as an immunogen
11/11/2004	US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
11/11/2004	US20040224305 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
11/11/2004	US20040223982 Neospora vaccine
11/11/2004	US20040223972 treatment of viral infections, including HIV infection, Marburg virus, and Ebola virus; detecting viral infected cells the antibodies
11/11/2004	US20040223970 Antibodies against SLC15A2 and uses thereof
11/11/2004	US20040223969 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223952 Generation and/or reduction of new lung tissue in an affected lung
11/11/2004	DE20320429U1 Detecting prion disease in a sample comprises contacting the sample with a diagnostically effective amount of an antibody having the ability to bind to PrP CTM in situ
11/11/2004	CA2826735A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2524360A1 Novel composition and methods for the treatment of immune disorders
11/11/2004	CA2524124A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2524071A1 Toll-like receptor 9 effector agents and uses thereof
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523798A1 Methods for prognosis and treatment of solid tumors
11/11/2004	CA2523792A1 Process for the production of biological substances by perfusion culturing of suspended animal cells
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases
11/11/2004	CA2523025A1 Spex compositions and methods of use
11/11/2004	CA2522779A1 Inducers of recombinant protein expression
11/11/2004	CA2521162A1 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	CA2501694A1 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same
11/10/2004	EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus

1 ... 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 ... 1494